InVivo Therapeutics
About Us
Our Technology
Our Pipeline
Patients & Families
Unmet Need
Physicians
Investors & Media
Press Releases
Presentations
Stock Information
Stock Quote
Stock Chart
SEC Filings
Corporate Governance
Governance Documents
Committee Composition
Investor FAQs
Email Alerts
About Us
Our Technology
Our Pipeline
Patients & Families
Unmet Need
Physicians
Investors & Media
Overview
Press Releases
Presentations
Stock Information
Stock Quote
Stock Chart
SEC Filings
Corporate Governance
Governance Documents
Committee Composition
Investor FAQs
Email Alerts
InVivo Therapeutics developing innovative products for spinal cord injury
Post navigation
Previous Post
Previous
High ASIA Impairment Scale conversion rate following scaffold Implantation in acute thoracic complete AIS A spinal cord injury (SCI): potential mechanisms
Next Post
Next
Translation of biomaterial-based therapies for the treatment of spinal cord injury: the Neuro-Spinal Scaffold™ and bioengineered neural trails™